These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30104903)

  • 1. Evaluation of antiretroviral effect on mitochondrial DNA depletion among HIV-infected patients in Bali.
    Masyeni S; Sintya E; Megawati D; Sukmawati NMH; Budiyasa DG; Aryastuti SA; Khairunisa SQ; Arijana I; Nasronudin N
    HIV AIDS (Auckl); 2018; 10():145-150. PubMed ID: 30104903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.
    Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN
    HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.
    Nolan D; Hammond E; Martin A; Taylor L; Herrmann S; McKinnon E; Metcalf C; Latham B; Mallal S
    AIDS; 2003 Jun; 17(9):1329-38. PubMed ID: 12799554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.
    Montaner JS; Côté HC; Harris M; Hogg RS; Yip B; Chan JW; Harrigan PR; O'Shaughnessy MV
    J Acquir Immune Defic Syndr; 2003 Sep; 34 Suppl 1():S85-90. PubMed ID: 14562863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood mitochondrial DNA/nuclear DNA (mtDNA/nDNA) ratio as a marker of mitochondrial toxicities of stavudine containing antiretroviral therapy in HIV-infected Malawian patients.
    Kampira E; Dzobo K; Kumwenda J; van Oosterhout JJ; Parker MI; Dandara C
    OMICS; 2014 Jul; 18(7):438-45. PubMed ID: 24816082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients.
    Subashini D; Dinesha TR; Srirama RB; Boobalan J; Poongulali S; Chitra DA; Mothi SN; Solomon SS; Saravanan S; Solomon S; Balakrishnan P
    Indian J Med Res; 2018 Aug; 148(2):207-214. PubMed ID: 30381544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion.
    McComsey G; Bai RK; Maa JF; Seekins D; Wong LJ
    J Acquir Immune Defic Syndr; 2005 Jun; 39(2):181-8. PubMed ID: 15905734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
    Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
    J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors.
    Reiss P; Casula M; de Ronde A; Weverling GJ; Goudsmit J; Lange JM
    HIV Med; 2004 Jan; 5(1):11-4. PubMed ID: 14731163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142.
    Hulgan T; Haubrich R; Riddler SA; Tebas P; Ritchie MD; McComsey GA; Haas DW; Canter JA
    AIDS; 2011 Jan; 25(1):37-47. PubMed ID: 20871389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.
    Hung KM; Chen PC; Hsieh HC; Calkins MJ
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):406-413. PubMed ID: 27840304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors.
    Martin AM; Hammond E; Nolan D; Pace C; Den Boer M; Taylor L; Moore H; Martinez OP; Christiansen FT; Mallal S
    Am J Hum Genet; 2003 Mar; 72(3):549-60. PubMed ID: 12587093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals.
    Gerschenson M; Shiramizu B; LiButti DE; Shikuma CM
    Antivir Ther; 2005; 10 Suppl 2():M83-9. PubMed ID: 16152709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial toxicity studied with the PBMC of children from the Chinese national pediatric highly active antiretroviral therapy cohort.
    Liu K; Sun Y; Liu D; Yin J; Qiao L; Shi Y; Dong Y; Li N; Zhang F; Chen D
    PLoS One; 2013; 8(2):e57223. PubMed ID: 23468942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients.
    Chiappini F; Teicher E; Saffroy R; Pham P; Falissard B; Barrier A; Chevalier S; Debuire B; Vittecoq D; Lemoine A
    Lab Invest; 2004 Jul; 84(7):908-14. PubMed ID: 15122308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue.
    Morse CG; Voss JG; Rakocevic G; McLaughlin M; Vinton CL; Huber C; Hu X; Yang J; Huang da W; Logun C; Danner RL; Rangel ZG; Munson PJ; Orenstein JM; Rushing EJ; Lempicki RA; Dalakas MC; Kovacs JA
    J Infect Dis; 2012 Jun; 205(12):1778-87. PubMed ID: 22476717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside reverse transcriptase inhibitors induced hepatocellular mitochondrial DNA lesions and compensatory enhancement of mitochondrial function and DNA repair.
    Liang Q; Zeng J; Wu J; Qiao L; Chen Q; Chen D; Zhang Y
    Int J Antimicrob Agents; 2018 Mar; 51(3):385-392. PubMed ID: 28843815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients.
    Bañó M; Morén C; Barroso S; Juárez DL; Guitart-Mampel M; González-Casacuberta I; Canto-Santos J; Lozano E; León A; Pedrol E; Miró Ò; Tobías E; Mallolas J; Rojas JF; Cardellach F; Martínez E; Garrabou G
    Front Genet; 2020; 11():497. PubMed ID: 32528527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.